News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Brian G.M. Durie reports the highlights of the IMWG Summit
Photo from International Myeloma Foundation/X
Jun 28, 2024, 14:23

Brian G.M. Durie reports the highlights of the IMWG Summit

International Myeloma Foundation shared on X:

“In his blog, IMF Chief Scientific Officer Dr. Brian G.M. Durie reports the highlights of the recently concluded 15th Annual International Myeloma Working Group (IMWG) Summit in Madrid, Spain.”

Source: International Myeloma Foundation/X

Brian G.M. Durie cancer IMWG International Myeloma Foundation Madrid OncoDaily Oncology
Special Coverage
Blog
Jul 26, 2025, 11:07
You Can Actually Do Clinical Research Even in a Limited-Resource Setting - Princess Máxima Center for Pediatric Oncology
Blog
Jul 26, 2025, 10:50
Gregg Margolis: Top Three Health Policy Articles
Blog
Jul 26, 2025, 10:41
Susanna Fletcher Greer: How a V Foundation Researcher Uncovered Our Hidden Power
Blog
Jul 26, 2025, 10:41
Rates of Early Onset Gastrointestinal Cancers are Rising Rapidly - Dana-Farber Cancer Institute
Blog
Jul 26, 2025, 10:29
Timothy Rebbeck: The Impact of Cancer Research Cuts
Blog
Jul 26, 2025, 10:20
Karen Knudsen: New U.S. Investments in Virginia Site will Expand Capacity and Save More Lives
Insight
Jul 26, 2025, 09:59
Jeffrey Hanna: Suicide and Head and Neck Cancer
Blog
Jul 26, 2025, 09:56
Herbert Loong: The Strong International Camaraderie Between Past and Present Fellows of the PMH Fellowship
Blog
Jul 26, 2025, 09:45
What is MET in Lung Cancer? - Lung Cancer Europe
Blog
Jul 26, 2025, 09:09
Alisha Kardian Has Received The 2025 Schweisguth Prize - SIOP
Blog
Jul 26, 2025, 08:45
Wafik El-Deiry: Important Discussions About NIH/NCI, Cancer Screening Initiatives and Community Outreach Events
Insight
Jul 26, 2025, 08:40
Hung Trinh: Pluripotent Stem-Cell-Derived Therapies in Clinical Trial